BNP/CALL/WALGREENS BOOTS ALLIANCE/32/0.1/17.01.25 Share Price

Warrant

DE000PE842E5

Delayed Deutsche Boerse AG 12:50:32 22/05/2024 BST
0.009 EUR 0.00% Intraday chart for BNP/CALL/WALGREENS BOOTS ALLIANCE/32/0.1/17.01.25
Current month-10.00%
1 month-43.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
22/05/24 0.009 0.00%
21/05/24 0.009 -30.77%
20/05/24 0.013 0.00%
17/05/24 0.013 +8.33%
16/05/24 0.012 +20.00%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 12:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying WALGREENS BOOTS ALLIANCE, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE842E
ISINDE000PE842E5
Date issued 14/02/2023
Strike 32 $
Maturity 17/01/2025 (240 Days)
Parity 10 : 1
Emission price 0.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.76
Lowest since issue 0.001
Spread 0.032
Spread %78.05%

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
16.68 USD
Average target price
22.77 USD
Spread / Average Target
+36.51%
Consensus